General AML

Prof. Norbert Vey | ASH 2017 | Key findings from the Effikir trial: lirilumab in AML

L: English
Watch French version

59th ASH Annual Meeting and Exposition, 9 - 1 Dec 2017, Atlanta, GA 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF